ACS Infectious Diseases · 2022 · 47 citations · 37 references
Life SciencesBiochemistryMicrobiologyAntimicrobial ResistanceDrug DiscoveryLipid BiochemistryAntibacterial PharmacologyAntibiotic ResistanceBiological MembranesLipid-protein InteractionsProtein-lipid InteractionsResistance In Gram-negative BacteriaBacterial Lipopolysaccharide RecognitionLipopeptide AntibioticsMembrane Disruption MechanismsOuter Membrane AnchoringOuter Membrane PermeabilityOuter Membrane ProteinsStereochemical MechanismsStereochemical Requirements
With increasing rates of resistance toward commonly used antibiotics, especially among Gram-negative bacteria, there is renewed interested in polymyxins. Polymyxins are lipopeptide antibiotics with potent anti-Gram-negative activity and are generally believed to target lipid A, the lipopolysaccharide (LPS) anchor found in the outer membrane of Gram-negative bacteria. To characterize the stereochemical aspects of their mechanism(s) of action, we synthesized the full enantiomers of polymyxin B and the polymyxin B nonapeptide (PMBN). Both compounds were compared with the natural compounds in biological and biophysical assays, revealing strongly reduced antibacterial activity for the enantiomeric species. The enantiomeric compounds also exhibit reduced LPS binding, lower outer membrane (OM) permeabilization, and loss of synergetic potential. These findings provide new insights into the stereochemical requirements underlying the mechanisms of action of polymyxin B and PMBN.
37
Yiyun Liu, Yang Wang, Timothy R. Walsh et al. · The Lancet Infectious Diseases · 2015 · 5.4K citations
Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane
Akshay Sabnis, Katheryn LH Hagart, Anna Klöckner et al. · eLife · 2021 · 391 citations · Full text